CORC

浏览/检索结果: 共11条,第1-10条 帮助

限定条件                
已选(0)清除 条数/页:   排序方式:
Pyrotinib or Lapatinib Combined With Capecitabine in HER2-Positive Metastatic Breast Cancer With Prior Taxanes, Anthracyclines, and/or Trastuzumab: A Randomized, Phase II Study 期刊论文
2019, 卷号: 37, 期号: 29, 页码: 2610-2619
作者:  Ma Fei;  Ouyang Quchang;  Li Wei;  Jiang Zefei;  Tong Zhongsheng
收藏  |  浏览/下载:33/0  |  提交时间:2020/01/03
A randomized phase II trial of pyrotinib plus capecitabine versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer previously treated with taxanes, anthracyclines and/or trastuzumab 会议论文
CANCER RESEARCH, 2018-02-01
作者:  Xu, Binghe;  Ma, Fei;  Ouyang, Quchang;  Li, Wei;  Jiang, Zefei
收藏  |  浏览/下载:15/0  |  提交时间:2020/01/03
A randomized phase II trial of pyrotinib plus capecitabine versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer previously treated with taxanes, anthracyclines and/or trastuzumab 期刊论文
2018, 卷号: 78, 期号: 4
作者:  Xu, Binghe;  Ma, Fei;  Ouyang, Quchang;  Li, Wei;  Jiang, Zefei
收藏  |  浏览/下载:9/0  |  提交时间:2020/01/03
Concurrent administration of trastuzumab and anthracyclines as adjuvant regimen for HER2-positive breast cancer: a randomised controlled trial 期刊论文
2017, 卷号: 8, 期号: 54, 页码: 92778-92787
作者:  Shen, Songjie;  Xu, Ying;  Zhou, Yidong;  Mao, Feng;  Guan, Jinghong
收藏  |  浏览/下载:3/0  |  提交时间:2020/01/03
Utidelone plus capecitabine versus capecitabine alone for heavily pretreated metastatic breast cancer refractory to anthracyclines and taxanes: a multicentre, open-label, superiority, phase 3, randomised controlled trial 期刊论文
2017, 卷号: 18, 期号: 3, 页码: 371-383
作者:  Zhang, Pin;  Sun, Tao;  Zhang, Qingyuan;  Yuan, Zhongyu;  Jiang, Zefei
收藏  |  浏览/下载:12/0  |  提交时间:2020/01/04
Efficacy and toxicity of vinorelbine (NVB)-based regimens in patients with metastatic triple negative breast cancer (mTNBC) pretreated with anthracyclines and taxanes 期刊论文
2015, 卷号: 37, 期号: 10, 页码: 788-92
作者:  Du Feng;  Yuan Peng;  Luo Yang;  Wang Jiayu;  Ma Fei
收藏  |  浏览/下载:3/0  |  提交时间:2020/01/04
A phase II study of capecitabine plus cisplatin in metastatic triple-negative breast cancer patients pretreated with anthracyclines and taxanes 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2015-05-20
作者:  Li, Qiao;  Xu, Binghe;  Li, Qing;  Zhang, Pin;  Yuan, Peng
收藏  |  浏览/下载:3/0  |  提交时间:2020/01/13
Cardiotoxicity evaluation of anthracyclines in zebrafish (Danio rerio) 期刊论文
2015, 卷号: 35, 期号: 3, 页码: 241-252
作者:  Han, Ying;  Zhang, Jing-pu;  Qian, Jian-qin;  Hu, Chang-qin
收藏  |  浏览/下载:2/0  |  提交时间:2020/01/13
A phase II study of capecitabine plus cisplatin in metastatic triple-negative breast cancer patients pretreated with anthracyclines and taxanes 期刊论文
2015, 卷号: 16, 期号: 12, 页码: 1746-1753
作者:  Li, Qiao;  Li, Qing;  Zhang, Pin;  Yuan, Peng;  Wang, Jiayu
收藏  |  浏览/下载:3/0  |  提交时间:2020/01/13
Is it safe to give anthracyclines concurrently with trastuzumab in neo-adjuvant or metastatic settings for HER2-positive breast cancer? A meta-analysis of randomized controlled trials 期刊论文
2014, 卷号: 31, 期号: 12, 页码: 340
作者:  Du, Feng;  Yuan, Peng;  Zhu, Wenjie;  Wang, Jiayu;  Ma, Fei
收藏  |  浏览/下载:5/0  |  提交时间:2020/01/13


©版权所有 ©2017 CSpace - Powered by CSpace